NCT00120900View on ClinicalTrials.gov

Evaluation of GW406381 in Treating Adults With Osteoarthritis Of The Knee

PHASE3CompletedINTERVENTIONAL
Enrollment

1,340

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
Osteoarthritis, Knee
Interventions
DRUG

GW406381

Trial Locations (19)

2317

GSK Investigational Site, Hamar

2635

GSK Investigational Site, Ishøj

3400

GSK Investigational Site, Lier

3731 DN

GSK Investigational Site, De Bilt

6644 CL

GSK Investigational Site, Ewijk

6416 EG

GSK Investigational Site, Heerlen

N-5068

GSK Investigational Site, Bergen

N-3515

GSK Investigational Site, Hønefoss

N-0370

GSK Investigational Site, Oslo

431-070

GSK Investigational Site, Anyang-si

705-718

GSK Investigational Site, Daegu

110-744

GSK Investigational Site, Seoul

120-752

GSK Investigational Site, Seoul

133-792

GSK Investigational Site, Seoul

135-710

GSK Investigational Site, Seoul

138-736

GSK Investigational Site, Seoul

Unknown

GSK Investigational Site, Seoul

GSK Investigational Site, San Juan

SE-252 78

GSK Investigational Site, Helsingborg

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY